Female fertility supplement protocol — what the trial evidence actually supports
Female fertility supplements range from items with strong neural-tube-defect-prevention evidence (folate, ideally as 5-MTHF) and oocyte-related trial signals (CoQ10 in older oocytes, myo-inositol in PCOS) to the much larger marketplace of "egg quality" stacks where the evidence is preliminary or absent. Reproductive medicine has converged on a small evidence-based supplement layer in trying-to-conceive populations; the broader supplement industry has not. This page focuses on what the trials actually show, with a deliberate emphasis on what to skip.
A small evidence-based supplement layer supports trying to conceive, but it works alongside reproductive medical care — cycle tracking, weight and lifestyle changes, and specialty evaluation — not instead of it. The strongest case is periconceptional folate (ideally 5-MTHF), which cuts neural tube defects by about 70%; vitamin D to target and, in PCOS, myo-inositol at 4 g/day for ovulation also have solid trial support, while CoQ10 has a smaller signal in older oocytes. The key caveat is that most marketed “egg quality” and “fertility blend” stacks are unproven and some carry periconceptional risk, so if you’ve been trying for 12 months (or 6 months at 35+), prioritise a fertility evaluation over supplement optimisation.
Read this first. If you've been trying to conceive for ≥12 months (or ≥6 months if 35+), have known or suspected PCOS, endometriosis, prior pregnancy losses, or known male-factor concern in your partner, the priority is fertility evaluation — semen analysis, ovarian reserve testing, tubal patency, ovulation assessment — not supplement optimisation. Supplements work alongside, not instead of, reproductive medical care.
What actually has trial evidence
Folate as 5-MTHF (or folic acid), 400–800 mcg/day
400 mcg/day starting at least 1 month before conception; 800 mcg or higher in users with prior NTD pregnancy or specific risk factors
The single most evidence-anchored fertility-related supplement: periconceptional folate reduces neural tube defects by ~70%. Standard prenatal vitamins include this. 5-MTHF (methylfolate) is the active form and bypasses MTHFR enzyme variants; folic acid works for most users. Start at least 30 days before stopping contraception.
Vitamin D3 to a 25-OH-D target of 30–50 ng/mL
2,000 IU/day typically; test 25-OH-D and supplement to target
Vitamin D deficiency is associated with adverse pregnancy outcomes and possibly reduced fertility. Repleting deficiency before conception is reasonable. Above-target supplementation does not appear to add fertility benefit. Test and supplement to target rather than blind high-dose.
Myo-inositol (with D-chiro-inositol in 40:1 ratio)
2 g myo-inositol twice daily (4 g/day total); 3–6 months minimum
Multiple RCTs in PCOS show myo-inositol improves ovulatory function, insulin sensitivity, and may improve oocyte quality (Unfer 2017 meta-analysis). The 40:1 myo:D-chiro ratio approximates the natural balance. Cost-effective compared to metformin and often better tolerated.
CoQ10 (ubiquinol) 200–600 mg/day in older oocytes
200–600 mg/day ubiquinol form preferred, 3+ months prior to attempted conception or IVF cycle
Small trials in women undergoing IVF, particularly those 35+, suggest CoQ10 may improve oocyte quality markers and fertilisation rates (Bentov 2014; subsequent reviews). Effect size is small and trial quality is mixed. Reasonable for older oocytes; not high-yield for younger users without specific concern.
Omega-3 EPA/DHA, 1 g/day (≥200 mg DHA)
≥200 mg DHA/day preconception and during pregnancy
DHA is incorporated into fetal brain and retinal tissue; maternal DHA status during pregnancy influences cord-blood DHA. Some signals on preterm birth reduction at higher doses. Standard component of modern prenatal recommendations.
Iron (in iron-deficient women planning pregnancy)
Ferrous bisglycinate 30 mg elemental iron every other day, if ferritin < 30–50 ng/mL
Iron deficiency is common in menstruating women and is associated with worse pregnancy outcomes if uncorrected. Test ferritin before supplementing routinely; over-supplementation in iron-replete women is not benign.
What dominates over supplements
- Cycle tracking and timed intercourse — ovulation prediction kits or fertility-awareness methods produce conception rate increases that supplement stacks don't approach.
- BMI normalisation — both overweight and underweight depress fertility; small body composition changes improve ovulatory function meaningfully.
- Smoking cessation — both partners; smoking is a major modifiable cause of subfertility and miscarriage.
- Moderate alcohol reduction — heavy alcohol intake depresses fertility; the safest preconception threshold is none, particularly close to ovulation.
- Sleep quality — shift work and chronic short sleep are independently associated with reduced fertility.
- Stress and mental health — fertility journeys are stressful; CBT, mindfulness, and structured psychological support improve outcomes and quality of life.
- Specialty evaluation — semen analysis (the cheapest, fastest fertility diagnostic; under-utilised), tubal patency studies, ovulation assessment, ovarian reserve testing.
What to skip
- "Fertility blends" with rooibos, vitex/chasteberry, maca, dong quai, and various honourable mentions — most ingredients lack RCT evidence in fertility; some have hormonal effects with insufficient safety data periconceptionally. Vitex in particular can be counterproductive depending on cycle phase.
- Megadose vitamin A retinol — chronic vitamin A > 10,000 IU/day is teratogenic; avoid high-dose vitamin A periconceptionally. Beta-carotene is safe; preformed retinol at high doses is not.
- DHEA in women without diminished ovarian reserve diagnosis — used in some fertility clinics for diminished ovarian reserve under specialist supervision, with mixed evidence; routine supplementation in non-DOR women is not indicated and has androgenic side effects.
- "Detox" cleanses, parasite cleanses, and elimination protocols — no fertility evidence; some are nutritionally compromised.
- High-dose antioxidant cocktails — the Cochrane review on antioxidants for female subfertility (2020) found low-quality evidence of any effect on live birth rate.
- CBD products marketed for fertility — no evidence; theoretical concerns periconceptionally.
- Black cohosh near conception — used for menopausal symptoms; not appropriate periconceptionally.
What to track
Conception is the primary endpoint; ovulation tracking (basal body temperature, LH kits) and cycle regularity are good interim metrics. For users with PCOS: cycle regularity and ovulation are direct markers of myo-inositol response. For users with vitamin D deficiency: serum 25-OH-D rise to target. Reassess at 3 months of supplement protocol if conception has not occurred and you've passed the "seek evaluation" threshold (12 months trying, or 6 months if 35+).
Practical quick-start. Standard prenatal vitamin starting at least 30 days before stopping contraception (contains 400–800 mcg folate/5-MTHF, 200+ mg DHA, iodine, iron). Add: vitamin D3 to 25-OH-D target. For PCOS: myo-inositol 4 g/day. For 35+ or known diminished ovarian reserve: CoQ10 ubiquinol 200–600 mg/day. Track ovulation. Seek fertility evaluation per the 12-month / 6-month thresholds.